DK1037650T3 - Præparater til behandling af Staphylococcus aureus-infektioner - Google Patents

Præparater til behandling af Staphylococcus aureus-infektioner

Info

Publication number
DK1037650T3
DK1037650T3 DK98964810T DK98964810T DK1037650T3 DK 1037650 T3 DK1037650 T3 DK 1037650T3 DK 98964810 T DK98964810 T DK 98964810T DK 98964810 T DK98964810 T DK 98964810T DK 1037650 T3 DK1037650 T3 DK 1037650T3
Authority
DK
Denmark
Prior art keywords
treatment
preparations
staphylococcus aureus
aureus infections
infection
Prior art date
Application number
DK98964810T
Other languages
Danish (da)
English (en)
Inventor
James W Larrick
Susan C Wright
Naomi Balaban
Original Assignee
Naomi Balaban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naomi Balaban filed Critical Naomi Balaban
Application granted granted Critical
Publication of DK1037650T3 publication Critical patent/DK1037650T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98964810T 1997-12-19 1998-12-18 Præparater til behandling af Staphylococcus aureus-infektioner DK1037650T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6809497P 1997-12-19 1997-12-19
US09/054,331 US6291431B1 (en) 1997-12-19 1998-04-02 Methods and compositions for the treatment and prevention of Staphylococcal infections

Publications (1)

Publication Number Publication Date
DK1037650T3 true DK1037650T3 (da) 2006-12-11

Family

ID=26732900

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98964810T DK1037650T3 (da) 1997-12-19 1998-12-18 Præparater til behandling af Staphylococcus aureus-infektioner

Country Status (10)

Country Link
US (2) US6291431B1 (de)
EP (1) EP1037650B1 (de)
AT (1) ATE335499T1 (de)
AU (1) AU2005099A (de)
CY (1) CY1106234T1 (de)
DE (1) DE69835536T2 (de)
DK (1) DK1037650T3 (de)
ES (1) ES2270540T3 (de)
PT (1) PT1037650E (de)
WO (1) WO1999032133A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
EP1188831B1 (de) * 1998-09-15 2007-12-05 Naomi Balaban Ziel des RNAIII activierenden Proteines (TRAP)
EP1862549A3 (de) * 1998-09-15 2008-02-13 Naomi Balaban Target eines RNAIII-aktivierenden Proteins (TRAP)
AU2001238115A1 (en) * 2000-02-10 2001-08-20 Intermune, Inc. Novel amino acid and peptide inhibitors of staphylococcus virulence
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
CN1569889A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 能与金葡菌自分泌的rnaiii激活蛋白结合的环多肽及其医药用途
EP1621203A1 (de) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibierende Peptide für die Behandlung von HIV-Infektion
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
AU2006244135A1 (en) * 2005-05-10 2006-11-16 Naomi Balaban Compositions for administering RNAIII-inhibiting peptides
EP2815754B1 (de) 2005-11-18 2016-06-08 Glanbia Nutritionals (Ireland) Limited Präparate zur Behandlung von Biofilm-assoziierten Infektionen
US20070248581A1 (en) * 2006-01-30 2007-10-25 The University Of Chicago Mgra is a redox regulator of antibiotic sensitivity and virulence
US20070293435A1 (en) * 2006-06-16 2007-12-20 Naomi Balaban Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections
AU2008242250B2 (en) 2007-04-19 2014-03-27 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
EP2872535A1 (de) 2012-07-16 2015-05-20 Pfizer Inc. Saccharide und verwendungen davon

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3043362B2 (ja) 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤
AU3825995A (en) 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus
ATE290548T1 (de) 1996-05-22 2005-03-15 Univ New York Expressionsblockierung von virulenten faktoren in s. aureus
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections

Also Published As

Publication number Publication date
AU2005099A (en) 1999-07-12
EP1037650A4 (de) 2004-10-20
DE69835536D1 (de) 2006-09-21
ATE335499T1 (de) 2006-09-15
ES2270540T3 (es) 2007-04-01
US7067135B2 (en) 2006-06-27
EP1037650A1 (de) 2000-09-27
CY1106234T1 (el) 2011-06-08
EP1037650B1 (de) 2006-08-09
PT1037650E (pt) 2006-12-29
DE69835536T2 (de) 2007-08-09
US20040077534A1 (en) 2004-04-22
US6291431B1 (en) 2001-09-18
WO1999032133A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
EA200000840A1 (ru) Антивирусные производные пиримидина
IL148079A0 (en) Human ctla-4 antibodies and compositions containing the same
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
DE60131138D1 (de) Antibakterielle mittel
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ID26043A (id) Turunan-turunan 1,3,5-triazina tertrisubstitusi untuk pengobatan infeksi-infeksi hiv
BR9914221B1 (pt) Derivados de glicopeptídeos e composições farmacêuticas contendo os mesmos
AP2000001942A0 (en) Use of organophosphoric compounds for the therapeutic and preventative treatment of infections.
ID21526A (id) 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus
DE60041753D1 (de) Arzneimittel zur behandlung von c. pneumoniae infektionen
DK0920421T3 (da) Isoxazolinderivater anvendelige som antimikrobielle midler
DK1077718T3 (da) Forøgelse af aktiviteten af antibakterielle oxazolidinon-midler ved anvendelse af argininderivater
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
DK1056454T3 (da) Anvendelse af makrolidforbindelser til behandling af glaukom
EP0932613A4 (de) Expressionsblockierung von virulenten faktoren in s. aureus
ATE166787T1 (de) Ein gegen staphylococcus-ganoderme-lucidum- extrakt enthaltendes antimikrobielles mittel
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
WO2004034961A3 (en) Antimicrobial agents and uses thereof
ATE420852T1 (de) Verfahren und zusammensetzungen zur behandlung oder prävention von bakteriellen infektionen
DK0896532T3 (da) Acylurinstofforbindelser til behandling af coccidioidomycose i varmblodede dyr
DK1459748T3 (da) (S,S)-reboxetin til behandling af perifer neuropati
DE69935662D1 (de) Mittel zur prävention/behandlung entzündlicher darmerkrankungen
PT1011329E (pt) Paclitaxeis de 7-metiltio-oxometilo e 7-metiltiodioxometilo
WO2004064784A3 (en) Composition and method for preventing or treating a virus infection